Comparison

Daxxify vs. Botox

House of Rose offers Daxxify and Botox for movement-related lines. Each product defines potency in its own units, so the unit count for one cannot be converted into the other. Formulation, labeled evidence, anatomy, and the treatment plan all belong in the comparison. See all treatment comparisons for the other reviewed pairs.

The main difference

The products use different, non-interchangeable units.

Botox contains onabotulinumtoxinA in a formulation with human albumin. Daxxify contains daxibotulinumtoxinA-lanm with the 35-amino-acid peptide excipient RTP004. Each label defines potency in units specific to that product, so a unit count cannot be converted from one to the other.

What still matters

Duration numbers only make sense with their study endpoints.

For moderate-to-severe glabellar lines, the Daxxify SAKURA trials reported about 24 weeks to their measured endpoint. A pooled Botox analysis reported 120 days among people who had responded by day 30. Those figures come from separate studies with different definitions rather than one head-to-head test.

Daxxify

Daxxify is daxibotulinumtoxinA-lanm and uses the peptide excipient RTP004 in its formulation.

Botox

Botox is onabotulinumtoxinA and includes human albumin and sodium chloride in its formulation.

Both products are available through the Neurotoxin Injections service.

Review Neurotoxin Injections

Comparison point	Daxxify	Botox
Active product	Daxxify · daxibotulinumtoxinA-lanm	Botox · onabotulinumtoxinA
Formulation distinction	Includes the 35-amino-acid RTP004 peptide excipient	Includes human albumin and sodium chloride
Onset evidence	Median 3 days to subject-rated improvement of at least 1 point in each SAKURA phase 3 trial	Label: chemical denervation typically begins 1–2 days after injection and increases during the first week
Glabellar-line duration evidence	Median 24.0 and 23.9 weeks maintaining none-or-mild severity at maximum frown in two phase 3 trials	Median 120 days among day-30 responders at maximum contraction in a pooled analysis
Downtime evidence	The label describes possible adverse reactions and injection-related effects rather than one universal downtime period	The label describes possible adverse reactions and injection-related effects rather than one universal downtime period

Individual outcomes vary.

Sources & limits

Where these numbers come from.

The duration figures come from separate studies with different products and study designs. They are not a dose-conversion table, a direct head-to-head trial, or a promise about an individual result.

Daxxify prescribing information
Product formulation, indication, warnings, reported adverse reactions, and unit non-interchangeability.
Botox Cosmetic prescribing information
Product formulation, labeled onset and duration language, warnings, reported adverse reactions, and unit non-interchangeability.
Daxxify SAKURA 1 and 2 phase 3 studies
Median subject-rated onset and response duration for moderate-to-severe glabellar lines.
Botox glabellar-line duration meta-analysis
Pooled median duration among day-30 responders.

Questions

What people ask about these two options.

Can Daxxify and Botox units be converted?

No. Daxxify and Botox units are product-specific and cannot be converted. Product selection, dose, and placement are determined for the individual treatment plan.

What do the duration figures actually compare?

They report product-specific glabellar-line study results: about 24 weeks to the measured Daxxify endpoint in SAKURA and 120 days among day-30 Botox responders in a pooled analysis. The studies used different endpoints and were not a head-to-head trial. Individual duration varies.

What do the sources say about onset and downtime?

The Daxxify SAKURA trials reported a median 3 days to subject-rated improvement of at least 1 point. The Botox Cosmetic label says chemical denervation typically begins 1 to 2 days after injection and increases during the first week. These are different measures. Both labels describe possible adverse reactions, but neither supplies a universal downtime period.

Ask a question about either service.

Call or send the two treatment names to House of Rose.

(941) 400-0165 Contact House of Rose